SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)
ALXN 182.500.0%Jul 28 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (748)3/20/2007 2:26:18 PM
From: Ian@SI  Read Replies (2) of 824
 
Clearly, ALXN, its backers and investors have taken a huge risk. Surely, the company should be rewarded for its successful effort.

Unless the public is willing to fund orphan drug development, I don't see any way that treatments would ever be developed for these diseases. And I really can't see the public ever fully funding drug development for a handful of citizens when there are masses going with inadequate health coverage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext